Favorable Response to High-Dose Infliximab for Refractory Childhood Uveitis
- 1 May 2006
- journal article
- case report
- Published by Elsevier in Ophthalmology
- Vol. 113 (5) , 860-864.e2
- https://doi.org/10.1016/j.ophtha.2006.01.005
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Anti–tumor necrosis factor α therapy and heart failure: What have we learned and where do we go from here?Arthritis & Rheumatism, 2004
- Tumor necrosis factor α blockade with infliximab for refractory uveitis and scleritisOphthalmology, 2004
- Does etanercept induce uveitis?British Journal of Ophthalmology, 2003
- Neutralizing Tumor Necrosis Factor-α Activity Suppresses Activation of Infiltrating Macrophages in Experimental Autoimmune UveoretinitisInvestigative Opthalmology & Visual Science, 2003
- Recurrent uveitis in a patient with juvenile spondyloarthropathy associated with tumour necrosis factor α inhibitorsAnnals of the Rheumatic Diseases, 2003
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialPublished by Elsevier ,2002
- Long-term follow-up of patients treated with short-term high-dose chlorambucil for sight-threatening ocular inflammationOphthalmology, 2002
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Neutralizing TNF-alpha Activity Modulates T-cell Phenotype and Function in Experimental Autoimmune UveoretinitisJournal of Autoimmunity, 1998
- Cytokines and uveitis, a reviewCurrent Eye Research, 1992